AFP and hepatocellular carcinoma: In the past 40 years, alpha-fetoprotein (AFP), as a unique HCC-specific serum marker, has been widely used in detecting, diagnosing, evaluating the treatment effect, and predicting recurrence of HCC and has played an important role.